References
- Balss J, Meyer J, Mueller W, et al (2008). Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathologica, 116, 597-602. https://doi.org/10.1007/s00401-008-0455-2
- Bleeker FE, Molenaar RJ, Leenstra S (2012). Recent advances in the molecular understanding of glioblastoma. J Neuro-Oncol, 108, 11-27. https://doi.org/10.1007/s11060-011-0793-0
- Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-8. https://doi.org/10.1038/nature07385
- Chen QG, Zhang Z, Yang Q, et al (2012). The role of zinc transporter ZIP4 in prostate carcinoma. Urologic Oncol, 30, 906-11. https://doi.org/10.1016/j.urolonc.2010.11.010
- Costello LC, Franklin RB (2013). A review of the current status and concept of the emerging implications of zinc and zinc transporters in the development of pancreatic cancer. Pancreat Disord Ther, Suppl 4.
- Costello LC, Levy BA, Desouki MM, et al (2011). Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma. Cancer Biol Ther, 12, 297-303. https://doi.org/10.4161/cbt.12.4.16356
- Dubbink HJ, Taal W, van Marion R, et al (2009). IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology, 73, 1792-5. https://doi.org/10.1212/WNL.0b013e3181c34ace
- Ducray F, Marie Y, Sanson M (2009). IDH1 and IDH2 mutations in gliomas. New England J Med, 360, 2248-9. https://doi.org/10.1056/NEJMc090593
- Duncan CG, Barwick BG, Jin G, et al (2012). A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res, 22, 2339-55. https://doi.org/10.1101/gr.132738.111
- Franklin RB, Levy BA, Zou J, et al (2012). ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J Gastrointest Cancer, 43, 249-57. https://doi.org/10.1007/s12029-011-9269-x
- Franz MC, Anderle P, Burzle M, et al (2013). Zinc transporters in prostate cancer. Mol Aspects Med, 34, 735-41. https://doi.org/10.1016/j.mam.2012.11.007
- Kambe T, Hashimoto A, Fujimoto S (2014). Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell Mol Life Sci, 71, 3281-95. https://doi.org/10.1007/s00018-014-1617-0
- Kim I, Kim CH, Seo GH, et al (2008). Inhibitory effect of zinc on hypoxic HIF-1 activation in astrocytes. Neuroreport, 19, 1063-6. https://doi.org/10.1097/WNR.0b013e328304d9ac
- Krell D, Mulholland P, Frampton AE, et al (2013). IDH mutations in tumorigenesis and their potential role as novel therapeutic targets. Future Oncol (London, England), 9, 1923-35. https://doi.org/10.2217/fon.13.143
- Wang J-B, Dong D-F, Wang M-D, et al (2014). IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in glioma cells in vitro and in vivo. Asian Pac J Cancer Prev, 15, 427-32. https://doi.org/10.7314/APJCP.2014.15.1.427
- Li M, Zhang Y, Liu Z, et al (2007). Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. P Natl Acad Sci USA, 104, 18636-41. https://doi.org/10.1073/pnas.0709307104
- Lichten LA, Cousins RJ (2009a). Mammalian zinc transporters: nutritional and physiologic regulation. Ann Rev Nutr, 29, 153-76. https://doi.org/10.1146/annurev-nutr-033009-083312
- Lichten LA, Cousins RJ (2009b). Mammalian zinc transporters: nutritional and physiologic regulation. Ann Rev Nutr, 29, 153-76. https://doi.org/10.1146/annurev-nutr-033009-083312
- Lin Y, Chen Y, Wang Y, et al (2013). ZIP4 is a novel molecular marker for glioma. Neuro Oncol, 15, 1008-16. https://doi.org/10.1093/neuonc/not042
- Lonnerdal B (2007). Trace element transport in the mammary gland. Ann Rev Nutr, 27, 165-77. https://doi.org/10.1146/annurev.nutr.27.061406.093809
- Maret W (2013). Zinc and human disease. Met Ions Life Sci, 13, 389-414. https://doi.org/10.1007/978-94-007-7500-8_12
- Martin AB, Aydemir TB, Guthrie GJ, et al (2013). Gastric and colonic zinc transporter ZIP11 (Slc39a11) in mice responds to dietary zinc and exhibits nuclear localization. J Nutr, 143, 1882-8. https://doi.org/10.3945/jn.113.184457
- Masica DL, Karchin R (2011). Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res, 71, 4550-61. https://doi.org/10.1158/0008-5472.CAN-11-0180
- Michalczyk A, Allen J, Blomeley R, et al (2002). Constitutive expression of hZnT4 zinc transporter in human breast epithelial cells. Biochem J, 364, 105-13. https://doi.org/10.1042/bj3640105
- Nardinocchi L, Pantisano V, Puca R, et al (2010). Zinc downregulates HIF-1alpha and inhibits its activity in tumor cells in vitro and in vivo. PloS One, 5, 15048. https://doi.org/10.1371/journal.pone.0015048
- Parsons DW, Jones S, Zhang X, et al (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-12. https://doi.org/10.1126/science.1164382
- Setty P, Hammes J, Rothamel T, et al (2010). A pyrosequencingbased assay for the rapid detection of IDH1 mutations in clinical samples. J Mol Diagnostics, 12, 750-6. https://doi.org/10.2353/jmoldx.2010.090237
- Taylor KM, Vichova P, Jordan N, et al (2008). ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology, 149, 4912-20. https://doi.org/10.1210/en.2008-0351
- Turcan S, Rohle D, Goenka A, et al (2012). IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature, 483, 479-83. https://doi.org/10.1038/nature10866
- Watanabe T, Nobusawa S, Kleihues P, et al (2009). IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol, 174, 1149-53. https://doi.org/10.2353/ajpath.2009.080958
- Zhao S, Lin Y, Xu W, et al (2009). Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science, 324, 261-5. https://doi.org/10.1126/science.1170944
Cited by
- Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration vol.29, pp.6, 2016, https://doi.org/10.1007/s10534-016-9971-z
- Zinc and zinc-containing biomolecules in childhood brain tumors vol.94, pp.11, 2016, https://doi.org/10.1007/s00109-016-1454-8
- SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-07830-4
- Zinc Transporter Proteins pp.1573-6903, 2017, https://doi.org/10.1007/s11064-017-2454-y